Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.94M Buy
158,388
+138,310
+689% +$2.76M 0.06% 175
2026
Q1
$378K Buy
+20,078
New +$377K 0.01% 548

Other funds holding NOV

Caxton Associates (UK)'s NOV Position: Q2 2026 in Review

Caxton Associates (UK) increased its NOV (NOV) stake by 689% in Q2 2026, buying an estimated $2.76M and bringing the position to 158,388 shares worth $2.94M. The position accounts for 0.06% of the portfolio, ranked #175.

Caxton Associates (UK) first reported a position in NOV in Q1 2026 and has held it in 2 quarters since. 488 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Caxton Associates (UK) held 158,388 shares of NOV worth $2.94M as of Q2 2026.
  • Caxton Associates (UK) bought 138,310 NOV shares in Q2 2026, an estimated $2.76M.
  • NOV made up 0.06% of Caxton Associates (UK)'s portfolio in Q2 2026, its #175 holding.
  • Caxton Associates (UK) first reported a position in NOV in Q1 2026 and has held it in 2 quarters since.
  • 488 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.